We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01144338
Recruitment Status : Completed
First Posted : June 15, 2010
Last Update Posted : September 1, 2017
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 21, 2017
  Study Completion Date : April 24, 2017
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):